Continuous Glucose Monitoring Guided Assessment of Concentrated 200 IU/Ml rDNA Human Premix 30/70 Insulin in Type 2 Diabetes Mellitus Patients

International Journal of Diabetes and Clinical Research
doi 10.23937/2377-3634/1410109
Full Text
Abstract

Available in full text

Date
Authors
Publisher

ClinMed International Library

Related search

Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes Mellitus Who Are Not Using Insulin

Cochrane Database of Systematic Reviews
2012English

Safety and Effectiveness of Biphasic Insulin Aspart 30/70 (NovoMix®30) When Switching From Human Premix Insulin in Patients With Type 2 Diabetes: Subgroup Analysis From the 6-Month IMPROVE™ Observational Study

International Journal of Clinical Practice
Medicine
2009English

Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Degludec in Patients With Type 2 Diabetes: A Randomized, Open-Label, Crossover Study Using Continuous Glucose Monitoring Profiles

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

Russian National Guidelines on Insulin Pump Therapy and Continuous Glucose Monitoring for Diabetes Mellitus Patients. DRAFT

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
2015English

Prevalence and Extent of Glycemic Excursions in Well-Controlled Patients With Type 2 Diabetes Mellitus Using Continuous Glucose-Monitoring System

Indian Journal of Medical Sciences
Medicine
2009English

Pdb86 - Cost-Utility Analysis of Insulin Glargine 300 U/Ml Versus Insulin Glargine 100 U/Ml and Insulin Degludec 100 U/Ml in Patients With Type 2 Diabetes Mellitus in Bulgaria

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Assessment of Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes Not Using Insulin

JAMA Internal Medicine
Internal Medicine
2019English

Clinical Use of Continuous Glucose Monitoring in Adults With Type 2 Diabetes

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2017English

Pdb79 - Cost-Utility Analysis of Insulin Glargine 300 U/Ml Versus Insulin Glargine 100 U/Ml and Insulin Degludec 100 U/Ml in Patients With Type 2 Diabetes Mellitus in Croatia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy